RNASE1 and non-small cell lung carcinoma: Interestingly, the average plasma RNase1 level was significantly higher in patients with RDAA than non-RDAA NSCLC group (426.654 ± 164.52 vs. 523.53 ± 56.57 ng/ml; Supplementary Fig. 4, d).